Molecular Epidemiology of Biliary Tree Cancers
-
- STATUS
- Recruiting
-
- days left to enroll
- 46
-
- participants needed
- 1500
-
- sponsor
- M.D. Anderson Cancer Center
Summary
This study is to learn if certain risk factors (environmental, viral, behavioral, medical, and dietary), tumor markers, and genetic changes can predict the development and outcome of biliary tree cancers. Establishing biomarkers models from patients may help doctors to further understand how biliary tree cancer is affected by different treatments, and why some people's cancer responds differently than others.
Description
PRIMARY OBJECTIVES:
I. To identify significant factors that may contribute to the etiology of biliary tree cancer.
II. To identify novel genetic loci that predispose to gallbladder cancers (GBC) and cholangiocarcinoma (CGC) diagnosis.
EXPLORATORY AND CORRELATIVE OBJECTIVES:
I. To use the collected blood and tissue materials for exploratory analysis to identify markers that predict prognosis of biliary tree cancers.
II. To correlate the identified markers with results of specific aim I and II to test the interaction between the identified markers with environmental and genetic factors.
- OUTLINE
Participants complete a questionnaire over 20 minutes. Participants also undergo collection of blood and leftover tissue samples.
Details
| Condition | Cholangiocarcinoma, Malignant Digestive System Neoplasm |
|---|---|
| Treatment | questionnaire administration, biospecimen collection |
| Clinical Study Identifier | NCT05179486 |
| Sponsor | M.D. Anderson Cancer Center |
| Last Modified on | 17 March 2022 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer